SPAZIANO, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 1.632
AS - Asia 1.147
NA - Nord America 922
SA - Sud America 270
AF - Africa 14
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.991
Nazione #
US - Stati Uniti d'America 903
RU - Federazione Russa 612
SG - Singapore 376
CN - Cina 316
IT - Italia 307
IE - Irlanda 295
BR - Brasile 230
HK - Hong Kong 181
DE - Germania 126
GB - Regno Unito 93
VN - Vietnam 86
KR - Corea 71
UA - Ucraina 69
IN - India 33
JP - Giappone 30
FI - Finlandia 24
FR - Francia 24
GR - Grecia 23
AR - Argentina 20
AT - Austria 15
TR - Turchia 14
NL - Olanda 11
CA - Canada 10
ID - Indonesia 10
BE - Belgio 9
EC - Ecuador 7
BD - Bangladesh 6
MX - Messico 6
SE - Svezia 6
AU - Australia 5
MA - Marocco 5
PL - Polonia 5
EG - Egitto 4
IQ - Iraq 4
PY - Paraguay 4
AL - Albania 3
PK - Pakistan 3
AZ - Azerbaigian 2
CO - Colombia 2
CZ - Repubblica Ceca 2
ES - Italia 2
LT - Lituania 2
NP - Nepal 2
PE - Perù 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
VE - Venezuela 2
ZA - Sudafrica 2
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 3.991
Città #
Dublin 295
Moscow 207
Hong Kong 176
Santa Clara 170
Singapore 153
Jacksonville 108
Chandler 102
Seoul 71
Hefei 64
Ann Arbor 46
Naples 43
Beijing 36
Ho Chi Minh City 36
Munich 36
Caserta 35
Princeton 29
Bremen 28
Medford 28
Ashburn 26
Roxbury 26
Bengaluru 24
Dearborn 20
Aversa 19
Düsseldorf 19
Nanjing 18
New York 17
The Dalles 17
Hanoi 16
Boardman 13
São Paulo 13
Woodbridge 13
Wilmington 12
Dallas 11
Los Angeles 11
Nuremberg 11
Arzano 9
Brussels 9
Des Moines 9
Guangzhou 8
Milan 8
Vienna 8
Afragola 7
Kunming 7
Napoli 7
Chicago 6
Dong Ket 6
Helsinki 6
Jinan 6
Mountain View 6
Rome 6
Curitiba 5
Falkenstein 5
Filderstadt 5
Fortaleza 5
Hebei 5
Jakarta 5
Norwalk 5
Porto Alegre 5
Ribeirão Preto 5
Shanghai 5
Sydney 5
Tokyo 5
Wuhan 5
Amsterdam 4
Arienzo 4
Bologna 4
Ha Long 4
Haiphong 4
Houston 4
Montreal 4
Nanchang 4
Niigata 4
Nocera Inferiore 4
Paris 4
Redwood City 4
Rio de Janeiro 4
San Mateo 4
Stockholm 4
Warsaw 4
Abbottabad 3
Americana 3
Baghdad 3
Belo Horizonte 3
Brooklyn 3
Campinas 3
Castellammare di Stabia 3
Denver 3
Guarulhos 3
Haikou 3
Hải Dương 3
London 3
Manaus 3
Niterói 3
Quito 3
Rochester 3
Salerno 3
Santos 3
Tucson 3
Turku 3
Acerra 2
Totale 2.248
Nome #
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events 250
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide. 134
Exposure to allergen causes changes in nts neural activities after intratracheal capsaicin application, in endocannabinoid levels and in the glia morphology of nts 118
Role of adiponectin in sphingosine-1-phosphate induced airway hyperresponsiveness and inflammation 116
Hydrogen sulfide inhalation ameliorates allergen induced airway hypereactivity by modulating mast cell activation 109
Intratracheal administration of mesenchymal stem cells modulates tachykinin system, suppresses airway remodeling and reduces airway hyperresponsiveness in an animal model 105
5α-dihydrotestosterone abrogates sex bias in asthma like features in the mouse 105
Functional contribution of sphingosine-1-phosphate to airway pathology in cigarette smoke-exposed mice 104
Novel series of benzoquinones with high potency against 5-lipoxygenase in human polymorphonuclear leukocytes 103
Gastroesophageal Reflux Disease and Airway Hyperresponsiveness: Mechanisms and Mediators Involved GERD and Asthma 103
Nociceptin reduces the inflammatory immune microenvironment in a conventional murine model of airway hyperresponsiveness 102
Disodium cromoglycate inhibits asthma-like features induced by sphingosine-1-phosphate 101
Toll-like receptor 4 is essential for the expression of sphingosine-1-phosphate-dependent asthma-like disease in mice 101
Formulation and characterization of solid lipid nanoparticles loading rf22-c, a potent and selective 5-lo inhibitor, in a monocrotaline-induced model of pulmonary hypertension 101
Lung Mesenchymal Stem Cells Ameliorate Elastase-Induced Damage in an Animal Model of Emphysema 100
Leukotriene-mediated sex dimorphism in murine asthma-like features during allergen sensitization 98
Skeletal Muscle Oxidative Metabolism in an Animal Model of Pulmonary Emphysema: Formoterol and Skeletal Muscle Dysfunction. 97
Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma 97
Association between Sex-Related ALOX5 Gene Polymorphisms and Lung Atopy Risk 89
SPHINGOSINE-1-PHOSPHATE/TGF- β AXIS DRIVES EPITHELIAL MESENCHYMAL TRANSITION IN ASTHMA-LIKE DISEASE 87
Circulating MicroRNAs Expression Profile in Lung Inflammation: A Preliminary Study 83
Montelukast improves symptoms and lung function in asthmatic women compared with men 83
Plasma glutamine decreases immediately after surgery and is related to incisiveness 82
Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand? 80
Design and synthesis of functionalized 4-aryl-Catechol derivatives as new antinflammatory agents with in vivo efficacy 80
Nociceptin/orphanin FQ receptor activation decreases the airway hyperresponsiveness induced by allergen in sensitized mice. 80
N/OFQ-NOP system and airways 80
Formulation of Solid Lipid Nanoparticles Loaded with Nociceptin/Orphanin FQ (N/OFQ) and Characterization in a Murine Model of Airway Hyperresponsiveness 79
StAR protein and steroidogenic enzyme expressions in the rat Harderian gland 79
Drug–drug interactions in vestibular diseases, clinical problems, and medico-legal implications 78
New Role of Adult Lung c-kit+ Cells in a Mouse Model of Airway Hyperresponsiveness 78
Lung microRNAs Expression in Lung Cancer and COPD: A Preliminary Study 73
Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: A therapeutic rationale approach 73
Nociceptin/Orphanin Fq in inflammation and remodeling of the small airways in experimental model of airway hyperresponsiveness 73
CARRIERS NANOTECNOLOGICI DEGLI AGONISTI DEL RECETTORE NOP 70
Similar programmed death ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancer 69
Effects of sex hormones on bronchial reactivity during the menstrual cycle 69
Orexin A induces a preference for higher ambient temperatures 67
Relationship between gender and the effectiveness of montelukast: An Italian/Danish register-based retrospective cohort study 67
The Role of MMPs in the Era of CFTR Modulators: An Additional Target for Cystic Fibrosis Patients? 66
miRNA Signatures in Alveolar Macrophages Related to Cigarette Smoke: Assessment and Bioinformatics Analysis 60
Protective Action of 3,5-Diiodo-L-Thyronine on Cigarette Smoke-Induced Mitochondrial Dysfunction in Human Alveolar Epithelial Cells 53
Simvastatin overcome HDAC2 expression in Non-Small Cell Lung Cancer (NSCLC Simvastatin Action Is Not Related to HDAC2 Expression in Non-Small Cell Lung Cancer (NSCLC). 52
The 5-lipoxygenase inhibitor RF-22c potently suppresses leukotriene biosynthesis in cellulo and blocks bronchoconstriction and inflammation in vivo 48
MicroRNA Monitoring in Human Alveolar Macrophages from Patients with Smoking-Related Lung Diseases: A Preliminary Study 46
Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma 42
Oxygen–Ozone Therapy in Cervicobrachial Pain: A Real-Life Experience 38
The effects of sulodexide on both clinical and molecular parameters in patients with mixed arterial and venous ulcers of lower limbs 32
Totale 4.100
Categoria #
all - tutte 15.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.886


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021140 0 0 0 0 0 16 32 20 17 25 23 7
2021/2022188 7 0 2 5 58 7 12 6 4 14 17 56
2022/2023527 35 2 18 20 70 48 4 23 268 4 26 9
2023/2024297 17 16 5 19 75 20 1 3 6 30 34 71
2024/2025864 18 54 16 22 110 101 129 76 88 101 55 94
2025/20261.534 136 243 226 184 319 426 0 0 0 0 0 0
Totale 4.100